NOVA ready to bounce back on lower support ?
Mis à jour
NOVA announced today that they've just earned Psilocybin Orphan Drug Designation in Europe that once approved would give them ten years of market exclusivity. Positive news are accumulating for this small biopharma over the last 3 months and at some point investors will start accumulating again as it sits on a well supported floor at .08
I keep adding slowly at the current range and would expect a quick run to .14-.15 as soon as some volume comes back (do you DD and own analysis!)
I keep adding slowly at the current range and would expect a quick run to .14-.15 as soon as some volume comes back (do you DD and own analysis!)
Note
Bouncing away from its support level on increasing volume so expecting it to test its first resistance at .14 this week now.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.